Funding for this research was provided by:
Bayer AG, Switzerland (Unrestricted research grant)
Received: 13 November 2022
Accepted: 11 April 2023
First Online: 21 April 2023
: All patients provided written informed consent. This study was conducted in accordance with relevant guidelines and regulations and also Good Clinical Practices and the study was approved by the Ticino Cantonal ethics committee (Protocol TI3849).
: Not applicable.
: The authors declare no competing interests.